Oral morphine is frequently used for breakthrough pain but the oral route is not always available and absorption is slow. The aim of this study was to explore the perspectives of healthcare professionals in the UK caring for children with life-limiting conditions concerning the assessment and management of breakthrough pain; prescribing and administration of transmucosal diamorphine compared with oral morphine; and the feasibility of a comparative clinical trial.
